Skip to main content
Clinical Trials/NCT06193109
NCT06193109
Completed
N/A

The Prognostic Impact of Right Ventricular Systolic Dysfunction on the Survival of Patients With Sepsis and Septic Shock

Burapha University1 site in 1 country200 target enrollmentOctober 1, 2022

Overview

Phase
N/A
Intervention
Not specified
Conditions
Sepsis and Septic Shock
Sponsor
Burapha University
Enrollment
200
Locations
1
Primary Endpoint
28 days in-hospital mortality
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

This study sought to evaluate the association of right ventricular systolic dysfunction and 28-day in-hospital mortality in patients with sepsis and septic shock. Prospective cohort study of adult patients admitted at Burapha university hospital from October 1, 2022 through June 30, 2023 for sepsis and septic shock, who had an echocardiogram within 72 hours after admission for evaluating right ventricular systolic function. Right ventricular systolic dysfunction was defned by the American Society of Echocardiography criteria. Outcomes included 28-day in-hospital mortality, maximal blood lactate, length of intensive care unit(ICU) stay and duration of mechanical ventilation.

Registry
clinicaltrials.gov
Start Date
October 1, 2022
End Date
July 30, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Sukrisd Koowattanatianchai

Assistant Professor Dr.

Burapha University

Eligibility Criteria

Inclusion Criteria

  • aged 18 years or older
  • diagnosed with sepsis or septic shock according to Sepsis-3 criteria
  • received an echocardiogram within 72 hours after admission

Exclusion Criteria

  • prior diagnosis of pulmonary hypertension,
  • cor-pulmonale,
  • significant valvular heart disease,
  • acute coronary syndrome,
  • aortic dissection,
  • heart failure
  • inability to follow up within 28 days

Outcomes

Primary Outcomes

28 days in-hospital mortality

Time Frame: October 1, 2022 and June 30, 2023

28 days in hospital mortality in patients with sepsis or septic shock

Secondary Outcomes

  • Duration of mechanical ventilation(October 1, 2022 and June 30, 2023)
  • The prevalence of right ventricular systolic dysfunction(October 1, 2022 and June 30, 2023)
  • Blood lactate levels(October 1, 2022 and June 30, 2023)
  • Lenght of ICU stay(October 1, 2022 and June 30, 2023)

Study Sites (1)

Loading locations...

Similar Trials